Health Equity
Bridging the Gap: Advancing Access to New Medications for Older Adults in Long-Term Care
PointClickCare Life Sciences
PAO-11-25-CL-07Nov 24, 2025
GLP-1
Bridging Boundaries in the GLP-1 Era: Pharma, Nutra, and Food Solutions
Aaron Lee; Jessica Zhang
Ingredients + Specialties from Univar Solutions
PAO-10-25-CL-01Oct 7, 2025
Insulin
Project Insulin: Rebuilding Insulin Access for Patients, Not Profit
David Alvaro, Ph.D.; Eric Moyal
Pharma's Almanac
PAO-09-25-CL-01Sep 16, 2025
GLP-1 Drugs
Body Image, GLP-1s, and Pharma’s Role
Maggie Palmiero
Pharma's Almanac
PAO-08-25-NI-11Aug 21, 2025
RWD
Unlocking the Power of Real-World Data in Long-Term Care
Jeff Wessinger
PointClickCare Life Sciences
PAO-04-25-CL-09Apr 25, 2025
Chronic Diseases
Breaking the Cycle of Chronic Disease with New Therapeutic Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-11Mar 2, 2025
Gene Therapy
Genprex Provides Update on Diabetes Gene Therapy Program
Genprex
PR-02-25-NI-15Feb 19, 2025
Cold Chain
Managing Temperature-Controlled Logistics for GLP-1 Drugs
Leandro Moreira
Frontier Scientific Solutions
PAO-02-25-CL-02Feb 5, 2025
Biotechs
Five Small Biotechs to Watch: February 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-01Feb 3, 2025
Column: New Drug Watch
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-08Jun 24, 2022
Diabetes Research
Composition of Gut Microbiome Predicts the Onset of Type 2 Diabetes
University of Turku
PR-M02-22-13Feb 16, 2022
Digital Therapeutics
Digital Therapeutics: Redefining Prescription Medication in the Information Era
David Kenion
Pharma's Almanac
PAO-05-21-NI-01May 6, 2021
New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S.
Eli Lilly and Company
PR-M04-20-NI-010-1621Apr 7, 2020
Insulin Delivery
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Abbott
PR-M02-20-NI-043Feb 27, 2020
Update
KalVista Pharmaceuticals Provides Update on Diabetic Macular Edema Programs
KalVista Pharmaceuticals, Inc.
PR-M02-20-NI-011Feb 11, 2020
Drug Pricing
Lilly Expands Insulin Affordability Options
Eli Lilly and Company
PR-M01-20-NI-028Jan 17, 2020
Diabetes
Sanofi to Exit Diabetes and Cardiovascular Research
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-19-NI-005Dec 13, 2019
Drug Approval
Qtrilmet Approved in the EU for the Treatment of Type-2 Diabetes
Nice Insight
PR-M11-19-NI-020Nov 19, 2019
Diabetes Prevention
Sigrid Therapeutics Takes Another Step Towards a Treatment for Prevention of Type 2 Diabetes
Nice Insight
PR-M10-19-NI-032Oct 24, 2019
Approval
Farxiga Approved in the US to Reduce the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes
AstraZeneca
PR-M10-19-NI-029Oct 22, 2019